Vaxart Inc (VXRT)
0.7478
-0.01
(-1.93%)
USD |
NASDAQ |
Apr 23, 16:00
0.7478
0.00 (0.00%)
After-Hours: 20:00
Vaxart Cash from Investing (TTM): 43.95M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 43.95M |
September 30, 2023 | 44.65M |
June 30, 2023 | 8.606M |
March 31, 2023 | 1.314M |
December 31, 2022 | -20.42M |
September 30, 2022 | -44.39M |
June 30, 2022 | -17.73M |
March 31, 2022 | -24.81M |
December 31, 2021 | -49.10M |
September 30, 2021 | -41.82M |
June 30, 2021 | -37.72M |
March 31, 2021 | -21.78M |
December 31, 2020 | -1.22M |
September 30, 2020 | -0.33M |
June 30, 2020 | -0.149M |
March 31, 2020 | -0.299M |
December 31, 2019 | -0.85M |
September 30, 2019 | -1.033M |
June 30, 2019 | -1.079M |
March 31, 2019 | -1.119M |
December 31, 2018 | 26.21M |
September 30, 2018 | 40.91M |
June 30, 2018 | 47.48M |
March 31, 2018 | 52.58M |
December 31, 2017 | 11.10M |
Date | Value |
---|---|
September 30, 2017 | -2.10M |
June 30, 2017 | -1.60M |
March 31, 2017 | -6.50M |
December 31, 2016 | 6.90M |
September 30, 2016 | 8.40M |
June 30, 2016 | 1.30M |
March 31, 2016 | -15.40M |
December 31, 2015 | -13.80M |
September 30, 2015 | -9.70M |
June 30, 2015 | -19.40M |
March 31, 2015 | -12.60M |
December 31, 2014 | -13.00M |
September 30, 2014 | -19.90M |
June 30, 2014 | -10.10M |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | 4.131M |
June 30, 2012 | 15.77M |
March 31, 2012 | 43.49M |
December 31, 2011 | 55.25M |
September 30, 2011 | 70.80M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-49.10M
Minimum
Dec 2021
44.65M
Maximum
Sep 2023
-8.642M
Average
-1.079M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Novavax Inc | -58.81M |
aTyr Pharma Inc | -20.13M |
Allogene Therapeutics Inc | 163.29M |
AIM ImmunoTech Inc | -0.832M |
Protalix BioTherapeutics Inc | -16.71M |